Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Vertex Pharmaceuticals Total Long-Term Assets 2010-2024 | VRTX

Vertex Pharmaceuticals total long-term assets from 2010 to 2024. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Vertex Pharmaceuticals total long-term assets for the quarter ending September 30, 2024 were $12.436B, a 76.89% increase year-over-year.
  • Vertex Pharmaceuticals total long-term assets for 2023 were $8.586B, a 74.65% increase from 2022.
  • Vertex Pharmaceuticals total long-term assets for 2022 were $4.916B, a 26.97% increase from 2021.
  • Vertex Pharmaceuticals total long-term assets for 2021 were $3.872B, a 7.01% increase from 2020.
  
Vertex Pharmaceuticals Annual Total Long-Term Assets
(Millions of US $)
2023 $8,586
2022 $4,916
2021 $3,872
2020 $3,618
2019 $3,496
2018 $2,403
2017 $897
2016 $1,065
2015 $1,091
2014 $788
2013 $730
2012 $1,170
2011 $873
2010 $668
2009 $648
Vertex Pharmaceuticals Quarterly Total Long-Term Assets
(Millions of US $)
2024-09-30 $12,436
2024-06-30 $11,191
2024-03-31 $10,629
2023-12-31 $8,586
2023-09-30 $7,030
2023-06-30 $6,476
2023-03-31 $6,009
2022-12-31 $4,916
2022-09-30 $4,435
2022-06-30 $4,079
2022-03-31 $3,895
2021-12-31 $3,872
2021-09-30 $3,766
2021-06-30 $3,764
2021-03-31 $3,576
2020-12-31 $3,618
2020-09-30 $3,843
2020-06-30 $3,522
2020-03-31 $3,447
2019-12-31 $3,496
2019-09-30 $2,737
2019-06-30 $2,323
2019-03-31 $2,360
2018-12-31 $2,403
2018-09-30 $934
2018-06-30 $928
2018-03-31 $912
2017-12-31 $897
2017-09-30 $870
2017-06-30 $1,105
2017-03-31 $1,075
2016-12-31 $1,065
2016-09-30 $1,108
2016-06-30 $1,095
2016-03-31 $1,085
2015-12-31 $1,091
2015-09-30 $1,075
2015-06-30 $1,079
2015-03-31 $808
2014-12-31 $788
2014-09-30 $756
2014-06-30 $770
2014-03-31 $767
2013-12-31 $730
2013-09-30 $934
2013-06-30 $868
2013-03-31 $826
2012-12-31 $1,170
2012-09-30 $1,084
2012-06-30 $1,012
2012-03-31 $910
2011-12-31 $873
2011-09-30 $846
2011-06-30 $936
2011-03-31 $666
2010-12-31 $668
2010-09-30 $662
2010-06-30 $650
2010-03-31 $644
2009-12-31 $648
2009-09-30 $659
2009-06-30 $657
2009-03-31 $664
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $105.754B $9.869B
Vertex Pharmaceuticals Incorporated is focused on the discovery, development, and commercialization of small molecule drugs targeting serious diseases. The company's main area of focus is cystic fibrosis. The company's lead marketed products are Trikafta, Symdeko/Symkevi, Orkambi and Kalydeco, which are collectively approved to treat the people with CF in North America, Europe and Australia. Trikafta, Vertex's triple combination regimen, was approved by the FDA for the treatment of CF in people aged 12 years and older who have at least one F508del mutation. While CF remains the main area of focus, Vertex is also developing treatments for sickle cell disease, beta thalassemia, APOL1-mediated kidney disease, type 1 diabetes, pain, alpha-1 antitrypsin deficiency and muscular dystrophies. Pimodivir/VX-787, for the treatment of influenza, was out-licensed to Janssen while oncology candidates VX-970, VX-984 and VX-803 were divested to Merck KGaA.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $141.468B 13.69
Gilead Sciences (GILD) United States $117.660B 21.31
Bristol Myers Squibb (BMY) United States $117.634B 49.57
CSL (CSLLY) Australia $85.763B 0.00
Regeneron Pharmaceuticals (REGN) United States $78.756B 17.93
GSK (GSK) United Kingdom $70.715B 8.18
Argenex SE (ARGX) Netherlands $38.155B 0.00
Alnylam Pharmaceuticals (ALNY) United States $31.278B 0.00
BioNTech SE (BNTX) Germany $27.275B 0.00
Biogen (BIIB) United States $21.843B 9.38
Illumina (ILMN) United States $21.405B 78.01
BeiGene (BGNE) Cayman Islands $18.010B 0.00
Moderna (MRNA) United States $15.558B 0.00
Genmab (GMAB) Denmark $13.619B 19.98
Incyte (INCY) United States $13.401B 0.00
BioMarin Pharmaceutical (BMRN) United States $12.773B 29.66
Insmed (INSM) United States $12.643B 0.00
Sarepta Therapeutics (SRPT) United States $11.784B 106.35
Bio-Techne Corp (TECH) United States $11.633B 44.92
Vaxcyte (PCVX) United States $10.691B 0.00
Exact Sciences (EXAS) United States $10.638B 0.00
QIAGEN (QGEN) Netherlands $10.271B 21.13
Swedish Orphan Biovitrum (BIOVF) Sweden $9.847B 40.68
Exelixis (EXEL) United States $9.718B 22.10
Bio-Rad Laboratories (BIO.B) United States $9.123B 31.00
Intra-Cellular Therapies (ITCI) United States $9.117B 0.00
Roivant Sciences (ROIV) United Kingdom $8.735B 0.00
Ascendis Pharma (ASND) Denmark $8.514B 0.00
Repligen (RGEN) United States $8.168B 106.41
Revolution Medicines (RVMD) United States $7.619B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.606B 7.44
Halozyme Therapeutics (HALO) United States $6.111B 13.80
Legend Biotech (LEGN) United States $5.987B 0.00
Nuvalent (NUVL) United States $5.831B 0.00
Blueprint Medicines (BPMC) United States $5.820B 0.00
Cytokinetics (CYTK) United States $5.728B 0.00
Telix Pharmaceuticals (TLX) Australia $5.510B 0.00
TG Therapeutics (TGTX) United States $5.215B 0.00
Alkermes (ALKS) Ireland $4.823B 16.20
Viking Therapeutics (VKTX) United States $4.756B 0.00
Krystal Biotech (KRYS) United States $4.616B 76.42
Scholar Rock Holding (SRRK) United States $4.281B 0.00
Arcellx (ACLX) United States $4.273B 0.00
Axsome Therapeutics (AXSM) United States $4.263B 0.00
ADMA Biologics Inc (ADMA) United States $4.229B 44.72
Apellis Pharmaceuticals (APLS) United States $4.099B 0.00
Ultragenyx Pharmaceutical (RARE) United States $4.047B 0.00
Guardant Health (GH) United States $3.876B 0.00
Alvotech (ALVO) Luxembourg $3.799B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $3.795B 0.00
Immunovant (IMVT) United States $3.777B 0.00
Avidity Biosciences (RNA) United States $3.713B 0.00
Biohaven (BHVN) United States $3.683B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.505B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $3.476B 0.00
Rhythm Pharmaceuticals (RYTM) United States $3.475B 0.00
NovoCure (NVCR) Jersey $3.452B 0.00
Denali Therapeutics (DNLI) United States $3.068B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.010B 0.00
Zai Lab (ZLAB) China $2.957B 0.00
Merus (MRUS) Netherlands $2.951B 0.00
Twist Bioscience (TWST) United States $2.922B 0.00
Amicus Therapeutics (FOLD) United States $2.919B 0.00
Janux Therapeutics (JANX) United States $2.895B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.890B 22.27
Vericel (VCEL) United States $2.847B 961.17
Edgewise Therapeutics (EWTX) United States $2.808B 0.00
SpringWorks Therapeutics (SWTX) United States $2.763B 0.00
Kymera Therapeutics (KYMR) United States $2.721B 0.00
Vera Therapeutics (VERA) United States $2.688B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $2.522B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.430B 0.00
Beam Therapeutics (BEAM) United States $2.377B 0.00
Protagonist Therapeutics (PTGX) United States $2.355B 14.85
Iovance Biotherapeutics (IOVA) United States $2.316B 0.00
IDEAYA Biosciences (IDYA) United States $2.235B 0.00
NeoGenomics (NEO) United States $2.218B 0.00
CG Oncology (CGON) United States $2.213B 0.00
Ligand Pharmaceuticals (LGND) United States $2.159B 53.89
Apogee Therapeutics (APGE) United States $2.124B 0.00
Bavarian Nordic (BVNRY) Denmark $2.105B 12.90
Mesoblast (MESO) Australia $2.088B 0.00
Tarsus Pharmaceuticals (TARS) United States $2.078B 0.00
WAVE Life Sciences (WVE) Singapore $2.056B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.018B 0.00
Akero Therapeutics (AKRO) United States $2.017B 0.00
Geron (GERN) United States $1.995B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.980B 16.45
Agios Pharmaceuticals (AGIO) United States $1.960B 0.00
Disc Medicine (IRON) United States $1.950B 0.00
Belite Bio (BLTE) United States $1.944B 0.00
MannKind (MNKD) United States $1.900B 49.21
ImmunityBio (IBRX) United States $1.874B 0.00
Neumora Therapeutics (NMRA) United States $1.832B 0.00
Galapagos (GLPG) Belgium $1.804B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.747B 0.00
Certara (CERT) United States $1.747B 49.32
Fortrea Holdings (FTRE) United States $1.720B 54.77
Dynavax Technologies (DVAX) United States $1.713B 100.23
Celldex Therapeutics (CLDX) United States $1.702B 0.00
Structure Therapeutics (GPCR) United States $1.691B 0.00
Viridian Therapeutics (VRDN) United States $1.571B 0.00
Immunocore Holdings (IMCR) United Kingdom $1.512B 0.00
Praxis Precision Medicines (PRAX) United States $1.458B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $1.452B 0.00
Arcus Biosciences (RCUS) United States $1.449B 0.00
Nurix Therapeutics (NRIX) United States $1.412B 0.00
Travere Therapeutics (TVTX) United States $1.388B 0.00
MiMedx (MDXG) United States $1.380B 36.12
Novavax (NVAX) United States $1.357B 0.00
Arvinas (ARVN) United States $1.311B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.301B 0.00
Spyre Therapeutics (SYRE) United States $1.238B 0.00
Intellia Therapeutics (NTLA) United States $1.234B 0.00
Myriad Genetics (MYGN) United States $1.229B 0.00
Gyre Therapeutics (GYRE) United States $1.228B 0.00
ANI Pharmaceuticals (ANIP) United States $1.167B 15.90
Septerna (SEPN) United States $1.144B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.103B 0.00
Rocket Pharmaceuticals (RCKT) United States $1.096B 0.00
Anavex Life Sciences (AVXL) United States $1.065B 0.00
Upstream Bio (UPB) United States $1.042B 0.00
Bicara Therapeutics (BCAX) United States $1.040B 0.00
Vir Biotechnology (VIR) United States $1.019B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $1.008B 0.00
Zymeworks (ZYME) United States $0.999B 0.00
Liquidia Technologies (LQDA) United States $0.999B 0.00
Adaptive Biotechnologies (ADPT) United States $0.950B 0.00
Nuvation Bio (NUVB) United States $0.949B 0.00
Poseida Therapeutics (PSTX) United States $0.930B 0.00
ArriVent BioPharma (AVBP) United States $0.929B 0.00
Pacira BioSciences (PCRX) United States $0.915B 8.61
AbCellera Biologics (ABCL) Canada $0.895B 0.00
LENZ Therapeutics (LENZ) United States $0.880B 0.00
Replimune (REPL) United States $0.875B 0.00
Cogent Biosciences (COGT) United States $0.869B 0.00
UniQure (QURE) Netherlands $0.864B 0.00
Pliant Therapeutics (PLRX) United States $0.854B 0.00
89BIO (ETNB) United States $0.850B 0.00
Prothena (PRTA) Ireland $0.847B 0.00
Immatics (IMTX) Germany $0.843B 0.00
Cytek Biosciences (CTKB) United States $0.841B 0.00
Avid Bioservices (CDMO) United States $0.785B 0.00
Castle Biosciences (CSTL) United States $0.759B 135.50
Tectonic Therapeutic (TECX) United States $0.755B 0.00
Cullinan Therapeutics (CGEM) United States $0.751B 0.00
Tyra Biosciences (TYRA) United States $0.744B 0.00
Erasca (ERAS) United States $0.741B 0.00
MBX Biosciences (MBX) United States $0.732B 0.00
Pharming Group (PHAR) Netherlands $0.719B 0.00
Rapport Therapeutics (RAPP) United States $0.705B 0.00
Kura Oncology (KURA) United States $0.698B 0.00
Immunome (IMNM) United States $0.693B 0.00
Oculis Holding AG (OCS) Switzerland $0.691B 0.00
CARGO Therapeutics (CRGX) United States $0.685B 0.00
CureVac (CVAC) Germany $0.683B 5.55
Keros Therapeutics (KROS) United States $0.681B 0.00
Dianthus Therapeutics (DNTH) United States $0.681B 0.00
Humacyte (HUMA) United States $0.666B 0.00
Entrada Therapeutics (TRDA) United States $0.664B 11.16
GRAIL (GRAL) United States $0.652B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Mineralys Therapeutics (MLYS) United States $0.641B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.612B 0.00
Arbutus Biopharma (ABUS) United States $0.604B 0.00
Stoke Therapeutics (STOK) United States $0.595B 0.00
Oric Pharmaceuticals (ORIC) United States $0.589B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.587B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.585B 0.00
Kodiak Sciences (KOD) United States $0.574B 0.00
Annexon (ANNX) United States $0.561B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.560B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.554B 0.00
Sangamo Therapeutics (SGMO) United States $0.549B 0.00
Astria Therapeutics (ATXS) United States $0.532B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.517B 0.00
CorMedix Inc (CRMD) United States $0.516B 0.00
Cartesian Therapeutics (RNAC) United States $0.505B 0.00
Terns Pharmaceuticals (TERN) United States $0.499B 0.00
Third Harmonic Bio (THRD) United States $0.488B 0.00
Celcuity (CELC) United States $0.486B 0.00
Abivax SA (ABVX) France $0.485B 0.00
Alpha Teknova (TKNO) United States $0.478B 0.00
MeiraGTx Holdings (MGTX) United States $0.478B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.459B 0.00
Emergent Biosolutions (EBS) United States $0.456B 0.00
Allogene Therapeutics (ALLO) United States $0.455B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.444B 0.00
MaxCyte (MXCT) United States $0.430B 0.00
ChromaDex (CDXC) United States $0.429B 561.00
Aura Biosciences (AURA) United States $0.420B 0.00
Zenas BioPharma (ZBIO) United States $0.420B 0.00
AnaptysBio (ANAB) United States $0.418B 0.00
Codexis (CDXS) United States $0.404B 0.00
Alumis (ALMS) United States $0.397B 0.00
IGM Biosciences (IGMS) United States $0.395B 0.00
REGENXBIO (RGNX) United States $0.390B 0.00
Prime Medicine (PRME) United States $0.386B 0.00
GH Research (GHRS) Ireland $0.380B 0.00
Sana Biotechnology (SANA) United States $0.380B 0.00
Contineum Therapeutics (CTNM) United States $0.375B 0.00
Design Therapeutics (DSGN) United States $0.367B 0.00
Olema Pharmaceuticals (OLMA) United States $0.362B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.358B 0.00
Neurogene (NGNE) United States $0.358B 0.00
Eton Pharmaceuticals (ETON) United States $0.354B 0.00
Northwest Biotherapeutics (NWBO) United States $0.351B 0.00
Sage Therapeutics (SAGE) United States $0.351B 0.00
Kamada (KMDA) Israel $0.347B 21.54
Absci (ABSI) United States $0.342B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.340B 0.00
Jasper Therapeutics (JSPR) United States $0.338B 0.00
Tango Therapeutics (TNGX) United States $0.335B 0.00
ACELYRIN, INC (SLRN) United States $0.333B 0.00
Trevi Therapeutics (TRVI) United States $0.324B 0.00
Voyager Therapeutics (VYGR) United States $0.323B 8.32
Revance Therapeutics (RVNC) United States $0.322B 0.00
XOMA Royalty (XOMA) United States $0.321B 0.00
ATyr Pharma (ATYR) United States $0.316B 0.00
Candel Therapeutics (CADL) United States $0.298B 0.00
Prima BioMed (IMMP) Australia $0.297B 0.00
Rezolute (RZLT) United States $0.290B 0.00
Chimerix (CMRX) United States $0.290B 0.00
Foghorn Therapeutics (FHTX) United States $0.283B 0.00
C4 Therapeutics (CCCC) United States $0.282B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.280B 0.00
Benitec Biopharma (BNTC) United States $0.279B 0.00
Atea Pharmaceuticals (AVIR) United States $0.278B 0.00
Lifecore Biomedical (LFCR) United States $0.276B 0.00
EnGene Holdings (ENGN) Canada $0.271B 0.00
ITeos Therapeutics (ITOS) United States $0.271B 0.00
AC Immune (ACIU) Switzerland $0.268B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.261B 0.00
Fulcrum Therapeutics (FULC) United States $0.261B 0.00
Urogen Pharma (URGN) United States $0.259B 0.00
Artiva Biotherapeutics (ARTV) United States $0.256B 0.00
Abeona Therapeutics (ABEO) United States $0.249B 0.00
Anika Therapeutics (ANIK) United States $0.244B 0.00
Ocugen (OCGN) United States $0.237B 0.00
DiaMedica Therapeutics (DMAC) United States $0.228B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.227B 0.00
Nautilus Biotechnology (NAUT) United States $0.224B 0.00
Cardiff Oncology (CRDF) United States $0.222B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.219B 0.00
Precigen (PGEN) United States $0.216B 0.00
Inhibrx Biosciences (INBX) United States $0.216B 0.00
Molecular Partners AG (MOLN) Switzerland $0.214B 0.00
BioStem Technologies (BSEM) $0.214B 18.86
BioAge Labs (BIOA) United States $0.211B 0.00
Opthea (OPT) Australia $0.210B 0.00
Compass Therapeutics (CMPX) United States $0.209B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.205B 0.00
Inozyme Pharma (INZY) United States $0.196B 0.00
Gossamer Bio (GOSS) United States $0.193B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.193B 0.00
TuHURA Biosciences (HURA) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.185B 0.00
Fate Therapeutics (FATE) United States $0.185B 0.00
Amarin (AMRN) Ireland $0.184B 0.00
Semper Paratus Acquisition (TVGN) United States $0.184B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.181B 0.00
Alector (ALEC) United States $0.178B 0.00
Bright Minds Biosciences (DRUG) United States $0.178B 0.00
Mersana Therapeutics (MRSN) United States $0.175B 0.00
Verastem (VSTM) United States $0.175B 0.00
Adherex Technologies (FENC) United States $0.175B 0.00
Innate Pharma S.A (IPHA) France $0.175B 0.00
Solid Biosciences (SLDB) United States $0.175B 0.00
Zura Bio (ZURA) United States $0.174B 0.00
Checkpoint Therapeutics (CKPT) United States $0.172B 0.00
Kyverna Therapeutics (KYTX) United States $0.172B 0.00
Coherus BioSciences (CHRS) United States $0.172B 0.00
ScPharmaceuticals (SCPH) United States $0.171B 0.00
Nkarta (NKTX) United States $0.171B 0.00
TScan Therapeutics (TCRX) United States $0.166B 0.00
Ventyx Biosciences (VTYX) United States $0.165B 0.00
Actuate Therapeutics (ACTU) United States $0.164B 0.00
Cidara Therapeutics (CDTX) United States $0.164B 0.00
Sutro Biopharma (STRO) United States $0.162B 0.00
2seventy Bio (TSVT) United States $0.158B 0.00
Seres Therapeutics (MCRB) United States $0.158B 0.00
Greenwich LifeSciences (GLSI) United States $0.156B 0.00
Sagimet Biosciences (SGMT) United States $0.156B 0.00
Aligos Therapeutics (ALGS) United States $0.156B 0.00
Abpro Holdings (ABP) United States $0.155B 0.00
Puma Biotechnology (PBYI) United States $0.155B 6.56
Caribou Biosciences (CRBU) United States $0.154B 0.00
InflaRx (IFRX) Germany $0.154B 0.00
Climb Bio (CLYM) United States $0.153B 0.00
Biomea Fusion (BMEA) United States $0.148B 0.00
Compugen (CGEN) Israel $0.145B 81.50
Adaptimmune Therapeutics (ADAP) United Kingdom $0.145B 0.00
Renovaro (RENB) United States $0.144B 0.00
Elutia (ELUT) United States $0.143B 0.00
Instil Bio (TIL) United States $0.140B 0.00
PepGen (PEPG) United States $0.140B 0.00
X4 Pharmaceuticals (XFOR) United States $0.137B 0.00
Monopar Therapeutics (MNPR) United States $0.134B 0.00
CAMP4 Therapeutics (CAMP) United States $0.131B 0.00
Black Diamond Therapeutics (BDTX) United States $0.130B 0.00
Seer (SEER) United States $0.129B 0.00
XBiotech (XBIT) United States $0.129B 0.00
Invizyne Technologies (IZTC) United States $0.128B 0.00
Tenaya Therapeutics (TNYA) United States $0.128B 0.00
Akoya Biosciences (AKYA) United States $0.122B 0.00
Cabaletta Bio (CABA) United States $0.122B 0.00
Alto Neuroscience (ANRO) United States $0.119B 0.00
Inventiva S.A (IVA) France $0.118B 0.00
TELA Bio (TELA) United States $0.115B 0.00
Leap Therapeutics (LPTX) United States $0.114B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.114B 0.00
Allakos (ALLK) United States $0.113B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.106B 0.00
INmune Bio (INMB) United States $0.105B 0.00
Adverum Biotechnologies (ADVM) United States $0.104B 0.00
Applied Therapeutics (APLT) United States $0.103B 0.00
Editas Medicine (EDIT) United States $0.102B 0.00
BioHarvest Sciences (BHST) Canada $0.100B 0.00
Nuvectis Pharma (NVCT) United States $0.097B 0.00
MediciNova (MNOV) United States $0.096B 0.00
Immunic (IMUX) United States $0.095B 0.00
Genenta Science S.p.A (GNTA) Italy $0.094B 0.00
HilleVax (HLVX) United States $0.093B 0.00
Coya Therapeutics (COYA) United States $0.091B 0.00
ALX Oncology Holdings (ALXO) United States $0.089B 0.00
CytomX Therapeutics (CTMX) United States $0.088B 6.65
Adagene (ADAG) China $0.087B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.087B 0.00
Bluebird Bio (BLUE) United States $0.085B 0.00
23andMe Holding (ME) United States $0.085B 0.00
Genelux (GNLX) United States $0.085B 0.00
Theratechnologies (THTX) Canada $0.084B 0.00
Cellectis S.A (CLLS) France $0.084B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.083B 0.00
Rani Therapeutics Holdings (RANI) United States $0.081B 0.00
Adlai Nortye (ANL) Cayman Islands $0.081B 0.00
Skye Bioscience (SKYE) United States $0.081B 0.00
FibroBiologics (FBLG) United States $0.080B 0.00
Adicet Bio (ACET) United States $0.079B 0.00
Alpha Cognition (ACOG) Canada $0.079B 0.00
Scilex Holding (SCLX) United States $0.079B 0.00
Oncolytics Biotech (ONCY) Canada $0.078B 0.00
Quince Therapeutics (QNCX) United States $0.077B 0.00
Entera Bio (ENTX) Israel $0.077B 0.00
Aadi Bioscience (AADI) United States $0.076B 0.00
Aerovate Therapeutics (AVTE) United States $0.076B 0.00
Ikena Oncology (IKNA) United States $0.076B 0.00
ZIVO Bioscience (ZIVO) United States $0.076B 0.00
Atara Biotherapeutics (ATRA) United States $0.075B 0.00
Generation Bio (GBIO) United States $0.074B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.074B 0.00
I-Mab (IMAB) China $0.073B 0.00
VistaGen Therapeutics (VTGN) United States $0.072B 0.00
Annovis Bio (ANVS) United States $0.071B 0.00
Galena Biopharma (SLS) United States $0.071B 0.00
Ovid Therapeutics (OVID) United States $0.071B 0.00
Werewolf Therapeutics (HOWL) United States $0.071B 0.00
Clearside Biomedical (CLSD) United States $0.071B 0.00
Cue Biopharma (CUE) United States $0.068B 0.00
Vigil Neuroscience (VIGL) United States $0.068B 0.00
Immuneering (IMRX) United States $0.068B 0.00
PDS Biotechnology (PDSB) United States $0.066B 0.00
Agenus (AGEN) United States $0.066B 0.00
BeyondSpring (BYSI) United States $0.065B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.064B 0.00
Invivyd (IVVD) United States $0.063B 0.00
Rapt Therapeutics (RAPT) United States $0.063B 0.00
BGM Group (BGM) China $0.063B 0.00
IO Biotech (IOBT) Denmark $0.062B 0.00
DBV Technologies S.A (DBVT) France $0.061B 0.00
Boundless Bio (BOLD) United States $0.059B 0.00
Immix Biopharma (IMMX) United States $0.058B 0.00
Vor Biopharma (VOR) $0.058B 0.00
Fortress Biotech (FBIO) United States $0.057B 0.00
Repare Therapeutics (RPTX) Canada $0.056B 0.00
Kronos Bio (KRON) United States $0.056B 0.00
Elicio Therapeutics (ELTX) United States $0.055B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.054B 0.00
Connect Biopharma Holdings (CNTB) United States $0.054B 0.00
Shattuck Labs (STTK) United States $0.053B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.053B 0.00
Dyadic (DYAI) United States $0.052B 0.00
Spero Therapeutics (SPRO) United States $0.051B 13.48
Kezar Life Sciences (KZR) United States $0.050B 0.00
Aileron Therapeutics (ALRN) United States $0.049B 0.00
Inovio Pharmaceuticals (INO) United States $0.049B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.047B 0.00
Celularity (CELU) United States $0.047B 0.00
Omega Therapeutics (OMGA) United States $0.046B 0.00
Exicure (XCUR) United States $0.045B 0.00
Q32 Bio (QTTB) United States $0.044B 0.00
VTv Therapeutics (VTVT) United States $0.043B 0.00
Xilio Therapeutics (XLO) United States $0.043B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.043B 0.00
Clene (CLNN) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.042B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.042B 0.00
Lexaria Bioscience (LEXX) Canada $0.041B 0.00
AN2 Therapeutics (ANTX) United States $0.041B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.041B 0.00
Passage Bio (PASG) United States $0.041B 0.00
CalciMedica (CALC) United States $0.041B 0.00
Oncobiologics (OTLK) United States $0.040B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.040B 0.00
SAB Biotherapeutics (SABS) United States $0.039B 0.00
Rallybio (RLYB) United States $0.038B 0.00
Lantern Pharma (LTRN) United States $0.038B 0.00
Grace Therapeutics (GRCE) Canada $0.038B 0.00
Enzo Biochem (ENZ) United States $0.037B 0.00
Precision BioSciences (DTIL) United States $0.036B 0.00
OKYO Pharma (OKYO) $0.036B 0.00
Elevation Oncology (ELEV) United States $0.035B 0.00
Opus Genetics (IRD) United States $0.034B 0.00
LakeShore Biopharma (LSB) China $0.033B 0.00
Beyond Air (XAIR) United States $0.032B 0.00
KALA BIO (KALA) United States $0.032B 0.00
Cognition Therapeutics (CGTX) United States $0.032B 0.00
Forte Biosciences (FBRX) United States $0.031B 0.00
BioAtla (BCAB) United States $0.031B 0.00
NKGen Biotech (NKGN) United States $0.031B 0.00
Medicus Pharma (MDCX) Canada $0.031B 0.00
RenovoRx (RNXT) United States $0.031B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.031B 0.00
Promis Neurosciences (PMN) Canada $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Dare Bioscience (DARE) United States $0.029B 0.00
Intensity Therapeutics (INTS) United States $0.029B 0.00
Chemomab Therapeutics (CMMB) Israel $0.029B 0.00
OnKure Therapeutics (OKUR) United States $0.027B 0.00
Longeveron (LGVN) United States $0.027B 0.00
Curis (CRIS) United States $0.027B 0.00
Femasys (FEMY) United States $0.026B 0.00
Lisata Therapeutics (LSTA) United States $0.026B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.026B 0.00
Pluri (PLUR) Israel $0.026B 0.00
Cocrystal Pharma (COCP) United States $0.025B 0.00
Cara Therapeutics (CARA) United States $0.025B 0.00
BRIACELL THERAP (BCTX) Canada $0.023B 0.00
Gelteq (GELS) Australia $0.023B 0.00
NextCure (NXTC) United States $0.023B 0.00
Prana Biotechnology (ATHE) Australia $0.023B 0.00
Pulmatrix (PULM) United States $0.023B 0.00
Equillium (EQ) United States $0.022B 0.00
HOOKIPA Pharma (HOOK) United States $0.022B 0.00
GeoVax Labs (GOVX) United States $0.022B 0.00
Bionano Genomics (BNGO) United States $0.022B 0.00
MiNK Therapeutics (INKT) United States $0.021B 0.00
Athira Pharma (ATHA) United States $0.021B 0.00
Affimed (AFMD) Germany $0.020B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.020B 0.00
Ocean Biomedical (OCEA) United States $0.020B 0.00
Bolt Biotherapeutics (BOLT) United States $0.020B 0.00
Tenax Therapeutics (TENX) United States $0.020B 0.00
Senti Biosciences (SNTI) United States $0.019B 0.00
IN8bio (INAB) United States $0.018B 0.00
Aprea Therapeutics (APRE) United States $0.018B 0.00
Spruce Biosciences (SPRB) United States $0.018B 0.00
UNITY Biotechnology (UBX) United States $0.017B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.017B 0.00
Synlogic (SYBX) United States $0.016B 0.00
Cyclo Therapeutics (CYTH) United States $0.016B 0.00
BioXcel Therapeutics (BTAI) United States $0.016B 0.00
HCW Biologics (HCWB) United States $0.016B 0.00
Palvella Therapeutics (PVLA) United States $0.016B 0.00
MetaVia (MTVA) United States $0.016B 0.00
Cingulate (CING) United States $0.015B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.015B 0.00
Aptose Biosciences (APTO) Canada $0.015B 0.00
BioAffinity Technologies (BIAF) United States $0.015B 0.00
CervoMed (CRVO) United States $0.015B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.014B 0.00
Novogen (KZIA) Australia $0.013B 0.00
Ensysce Biosciences (ENSC) United States $0.012B 0.00
Sensei Biotherapeutics (SNSE) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Imunon (IMNN) United States $0.011B 0.00
Apollomics (APLM) United States $0.011B 0.00
Turnstone Biologics (TSBX) United States $0.011B 0.00
Biorestorative Therapies (BRTX) United States $0.011B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
Aytu BioPharma (AYTU) United States $0.009B 0.00
Mainz Biomed (MYNZ) Germany $0.009B 0.00
Evogene (EVGN) Israel $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.009B 0.00
Mustang Bio (MBIO) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
GENPREX (GNPX) United States $0.008B 0.00
Polyrizon (PLRZ) Israel $0.007B 0.00
ABVC BioPharma (ABVC) United States $0.007B 0.00
Soligenix (SNGX) United States $0.007B 0.00
Galecto (GLTO) Denmark $0.007B 0.00
GRI Bio (GRI) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Alzamend Neuro (ALZN) United States $0.007B 0.00
Adial Pharmaceuticals (ADIL) United States $0.007B 0.00
Carmell (CTCX) United States $0.007B 0.00
Quantum Biopharma (QNTM) Canada $0.007B 0.00
CNS Pharmaceuticals (CNSP) United States $0.007B 0.00
Edesa Biotech (EDSA) Canada $0.006B 0.00
Elevai Labs (ELAB) United States $0.006B 0.00
Vincerx Pharma (VINC) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Syros Pharmaceuticals (SYRS) United States $0.006B 0.00
Purple Biotech (PPBT) Israel $0.006B 0.00
Moleculin Biotech (MBRX) United States $0.006B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.005B 0.00
Organovo Holdings (ONVO) United States $0.005B 0.00
Evaxion Biotech (EVAX) Denmark $0.005B 0.00
Allarity Therapeutics (ALLR) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
Silo Pharma (SILO) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.004B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
NAYA Biosciences (NAYA) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Atrinsic (PTIX) United States $0.004B 0.00
Sunshine Biopharma (SBFM) United States $0.004B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.004B 0.00
Pasithea Therapeutics (KTTA) United States $0.004B 0.00
NuCana (NCNA) United Kingdom $0.004B 0.00
Dogwood Therapeutics (DWTX) United States $0.003B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.003B 0.00
Artelo Biosciences (ARTL) United States $0.003B 0.00
Titan Pharmaceuticals (TTNP) United States $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.003B 0.00
180 Life Sciences (ATNF) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Windtree Therapeutics (WINT) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.003B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
Citius Oncology (CTOR) United States $0.002B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Psyence Biomedical (PBM) Canada $0.002B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.002B 0.00
Eterna Therapeutics (ERNA) United States $0.002B 0.00
Revelation Biosciences (REVB) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
NeuBase Therapeutics (NBSE) United States $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00